Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Cutter

Showing results (261-270 of 296) with videos related to

Pageof 30
Sort By:
Neurorehabilitation and Neural Repair|May 4, 2025
Correlates of Processing Speed Change With Combined Cognitive Rehabilitation and Exercise in Progressive MS: Secondary Analysis of the CogEx TrialBrian M Sandroff, Robert W Motl, Roberto S Hernandez, et al.
Archives of Neurology|November 11, 2009
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosisBryn M Burkholder, Benjamin Osborne, Michael J Loguidice, et al.
BMC Cancer|November 11, 2010
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcomaBeth A Tamburini, Tzu L Phang, Susan P Fosmire, et al.
Cancer Gene Therapy|August 29, 2003
Enhancing antimelanoma immune responses through apoptosisStacie R Bianco, Juan Sun, Susan P Fosmire, et al.
Neurology|May 5, 2019
Hand stereotypies: Lessons from the Rett Syndrome Natural History StudyJennifer L Stallworth, Marisela E Dy, Caroline B Buchanan, et al.
The Lancet. Neurology|May 17, 2024
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trialBruce A C Cree, Ho Jin Kim, Brian G Weinshenker, et al.
Pediatric Neurology|May 19, 2020
Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis ComplexLeslie E Grayson, Jurriaan M Peters, Tarrant McPherson, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b studyGavin Giovannoni, Laura Airas, Riley Bove, et al.
Neurorehabilitation and Neural Repair|March 1, 2024
Prevalence and Associated Clinical Characteristics of Walking-Related Motor, Cognitive, and Fatigability in Progressive Multiple Sclerosis: Baseline Results From the CogEx StudyCintia Ramari, Mieke D'hooge, Ulrik Dalgas, et al.
Neurology|June 8, 2023
Polygenicity of Comorbid Depression in Multiple SclerosisKaarina Kowalec, Kathryn C Fitzgerald, Amber Salter, et al.
Pageof 30

Showing results (261-270 of 296) with videos related to

Sort By:
Pageof 30
Neurorehabilitation and Neural Repair|May 4, 2025
Correlates of Processing Speed Change With Combined Cognitive Rehabilitation and Exercise in Progressive MS: Secondary Analysis of the CogEx TrialBrian M Sandroff, Robert W Motl, Roberto S Hernandez, et al.
Archives of Neurology|November 11, 2009
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosisBryn M Burkholder, Benjamin Osborne, Michael J Loguidice, et al.
BMC Cancer|November 11, 2010
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcomaBeth A Tamburini, Tzu L Phang, Susan P Fosmire, et al.
Cancer Gene Therapy|August 29, 2003
Enhancing antimelanoma immune responses through apoptosisStacie R Bianco, Juan Sun, Susan P Fosmire, et al.
Neurology|May 5, 2019
Hand stereotypies: Lessons from the Rett Syndrome Natural History StudyJennifer L Stallworth, Marisela E Dy, Caroline B Buchanan, et al.
The Lancet. Neurology|May 17, 2024
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trialBruce A C Cree, Ho Jin Kim, Brian G Weinshenker, et al.
Pediatric Neurology|May 19, 2020
Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis ComplexLeslie E Grayson, Jurriaan M Peters, Tarrant McPherson, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b studyGavin Giovannoni, Laura Airas, Riley Bove, et al.
Neurorehabilitation and Neural Repair|March 1, 2024
Prevalence and Associated Clinical Characteristics of Walking-Related Motor, Cognitive, and Fatigability in Progressive Multiple Sclerosis: Baseline Results From the CogEx StudyCintia Ramari, Mieke D'hooge, Ulrik Dalgas, et al.
Neurology|June 8, 2023
Polygenicity of Comorbid Depression in Multiple SclerosisKaarina Kowalec, Kathryn C Fitzgerald, Amber Salter, et al.
Pageof 30